Chromosomal rearrangements and their relations to histopathological and clinical parameters in epithelial ovarian cancer

Folia Biologica

Volumn 54, Issue 2, 2008, Pages 58-64

  Jančárková, Natalia ^a   Krkavcova M ^a   Janashia, M ^a   Freitag, P ^a   Duskova J ^a   Cibula, D ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; KI 67 ANTIGEN; PLATINUM; PROTEIN P53; TAXANE DERIVATIVE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER GENETICS; CANCER GRADING; CHROMOSOME 22Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME PAINTING; CHROMOSOME REARRANGEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY CELL; PROGNOSIS;

EID: 44649153111     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Aunoble, B., Sanches, R., Didier, E., Bignon, Y. J. (2000) Major oncogenes and tumor supressor genes involved in epithelial ovarian cancer. Int. J. Oncol. 16, 567-576.
2. Baron, A. T., Boardman, C. H., Lafky, J. M., Rademaker, A., Liu, D., Fishman, D. A., Podratz, K. C., Maihle, N. J. (2005) Soluble epidermal growth factor receptor (SEG-FR) and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer. Cancer Epidem. Biomar. 13, 306-318.
3. Bartoňková, H., Foretová, L., Helmichová, E., Kalábová, R., Kleibl, Z., Konopásek, B., Krutílková, V., Macháčková, E., Novotný, J., Petráková, K., Petruželka, L., Plevová, P., Pohlreich, P., Rob, L., Skovajsová, M., Veselý, J., Žaloudík, J. (2003) Recommendations for care of patients with breast and ovarian cancer and healthy individuals with germline mutations in BRCA1 or BRCA2 gene. Klin. Onkol. 1, 28-34 (in Czech).
4. Choi, Y.-W., Bae, S. M., Kim, Y.-W., Lee, H. N., Kim, Y. W., Park, T. C., Ro, D. Y., Shin, J. C., Shin, S. J., Seo, J. S., Ahn, W.-S. (2007) Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis. Int. J. Gynecol. Cancer 17, 687-696.
5. Fishman, A., Shalom-Paz, E., Fejgin, M., Gaber, E., Altaras, M., Amiel, A. (2005) Comparing the genetic changes detected in the primary and secondary tumor sites of ovarian cancer using comparative genomic hybridization. Int. J. Gynecol. Cancer 15, 261-266.
6. Geisler, J. P., Geisler, H. E. (2001) Tumor markers and molecular biological markers in gynecological malignancies. Curr. Opin. Obstet. Gynecol. 13, 31-39.
7. Gospodarowicz, M. K, Henson, D. E., Hutter, R. V. P., O'Sullivan, B., Sobin, L. H., Wittekind, C. (Eds.) (2001) Prognostic Factors in Cancer. 2nd ed. UICC. Wiley-Liss, New York.
8. Hauptmann, S., Denkert, C., Koch, I., Petersen, S., Schluns, K., Reles, A., Dietel, M., Petersen, I. (2002) Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Hum. Pathol. 33, 632-641.
9. Helou, K., Padilla-Nash, H., Wangsa, D., Karlsson, E., Osterberg, L., Karlsson P., Ried, T., Knutsen, T. (2006) Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant tumors. Cancer Genet. Cytogenet. 170, 1-8.
10. Hu, J., Khanna, V., Jones, M. M., Surti, U. (2003) Comparative study of primary and recurrent serous ovarian carcinomas: comparative genomic hybridization analysis with a potential application for prognosis. Gynecol. Oncol. 89, 369-375.
11. Huang, N. F., Gupta, M., Varghese, S., Rao, S., Luke, S. (2002) Detection of numerical chromosomal abnormalities in epithelial ovarian neoplasms by fluorescence in situ hybridization (FISH) and a review of the current literature. Appl. Immunohistochem. Mol. Morphol. 10, 187-193.
12. Jackson, E. M., Shaikh, T. H., Gururangan, S., Jones, M. C., Malkin, D., Nikkel, S. M., Zuppan, C. W., Wainwright, L. M., Zhang, F., Biegel, J. A. (2007) High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor. Hum. Genet. 122, 117-127.
13. Kiechle, M., Jacobsen, A., Schwarz-Boeger, U., Hedderich, J., Pfisterer, J., Arnold, N. (2001) Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation. Cancer 91, 534-540.
14. Kim, G. J., Kim, J. O., Hong, E. K., Kim, H., Chun, Y. H., Park, S. H. (2003) Detection of genetic alterations in Korean ovarian carcinomas by degenerate oligonucleotide primed polymerase-chain reaction - comparative genomic hybridization. Cancer Genet. Cytogenet. 147, 23-27.
15. Loukopoulos, P., Shibata, T., Katoh, H., Kokubu, A., Sakamoto, M., Yamazaki, K., Kosuge, T., Kanai, Y., Hosoda, F., Imoto, I., Ohki, M., Inazawa, J., Hirohashi, S. (2007) Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome. Cancer Sci. 98, 392-400.
16. Mark, H. F., Afify, A. M., Werness, B. A., Das, S., Mark, S., Samy, M. (1999) Trisomy 8 in stage I and stage III ovarian cancer detected by FISH. Exp. Mol. Pathol. 66, 76-81.
17. Mc Carty, K. S. Jr., Miller, L. S., Cox, E. B., Konrath, J., Mc Carty, K. S. Sr. (1985) Estrogen receptor analyses: Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch. Pathol. Lab. Med. 109, 716-721.
18. Mitelman, F. (Ed.) (1995) An International System for Human Cytogenetic Nomenclature, S. Karger, Basel, Switzerland.
19. Nielsen, J. S., Jakobsen, E., Holund, B., Bertelsen, K., Jakobsen, A. (2004) Prognostic significance of p53, Her-2 and EGFR overexpression in borderline and epithelial ovarian cancer. Int. J. Gynecol. Cancer 14, 1086-1091.
20. Osterberg, L., Åkeson, M., Levan, K., Partheen, K., Zetterqvist, B.-M., Brännstrom, M., Horvath, G. (2006) Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas. Cancer Genet. Cytogenet. 167, 103-108.
21. Panani, A. D., Roussos, C. (2006) Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality. Cancer Lett. 235, 130-135.
22. Patael-Karasik, Y., Daniely, M., Gotlieb, W. H., Ben-Baruch, G., Schiby, J., Barakai, G., Goldman, B., Aviram, A., Friedman, E. (2000) Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel. Cancer Genet. Cytogenet. 121, 26-32.
23. Pieretti, M., Hopenhayn-Rich, C., Khattar, N. H, Cao, Y., Huang, B., Tucker, T. C. (2002) Heterogenity of ovarian cancer: relationship among histological group, stage of disease, tumor markers, patient characteristics and survival. Cancer Invest. 20, 11-23.
24. Sah, S. P., Dawar, R., Kumar, L., Gupta, S. D. (2004) Nucleolar organizer regions as a prognostic indicator in epithelial cancer of the ovary. Int. J. Gynecol. Pathol. 23, 347-353.
25. Sham, J. S., Tang, T. C., Fang, Y., Sun, L., Qin, L.-X., Wu, Q.-L., Xie, D., Guan, X.-Y. (2002) Recurrent chromosome alterations in primary ovarian carcinomas in Chinese women. Cancer Genet. Cytogenet. 133, 39-44.
26. Shridhar, V., Lee, J., Pandita, A., Iturria, S., Avula, R., Staub, J., Morrissey, M., Calhoun, E., Sen, A., Kalli, K., Keeney, G., Roche, P., Cliby, W., Lu, K., Schmandt, R., Mills, G. B., Bast, R. C. Jr., James, C. D., Couch, F. J, Hartmann, L. C., Lillie, J., Smith, D. I. (2001) Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res. 61, 5895-5904.
27. Staebler, A., Heselmeyer-Haddad, K., Bell, K., Riopel, M., Perlman, E., Ried, T., Kurman, R. J. (2002) Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas. Hum. Pathol. 33, 47-52.
28. Stewart, B. W., Kleihues P. (Eds.) (2003) World Cancer Report (WHO). IARC Press, Lyon, France.
29. Tapper, J., Sarantaus L., Vahteristo, P., Nevanlinna, H., Hemmer, S., Seppala, M., Knuutila, S., Butzow, R. (1998) Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: extensive similarity except for a difference at chromosome 2q24-q32. Cancer Res. 58, 2715-2719.
30. Teixeira, N. R. (2002) Combined classical and molecular cytogenetic analysis of cancer. Eur. J. Cancer 38, 1580-1584.
31. Tibiletti, M.A., Bernasconi, B., Taborelli, M., Facco, C., Riva, C., Capella, C., Franchi, M., Binelli, G., Acquati, F., Taramelli, R. (2003) Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesis. Cancer Genet. Cytogenet. 146, 145-153.
32. Villa, A., Parazzini, F., Acerboni, S., Guarnerio, P., Bolis, G. (1998) Survival and prognostic factors of early ovarian cancer. Br. J. Cancer 77, 123-124.
33. Wang, Y., Helland, A., Holm, R., Skomedal, H., Abeler, V. M., Danielsen, H. E., Tropé, C. G., Borresen-Dale, A.-L., Kristense, G. B. (2004) TP53 mutations in early-stage ovarian carcinoma, relation to long term survival. Br. J. Cancer 90, 678-685.
34. Wieser, R., Fritz, B., Ullmann, R., Müller, I., Galhuber, M., Storlazzi, C. T., Ramaswamy, A., Christiansen, H., Shimizu, N., Rehder, H. (2005) Novel rearrangements of chromosome band 22q11.2 causing 22q11 microdeletion syndrome-like phenotype and rhabdoid tumor of the kidney. Hum. Mutat. 26, 78-83.